Bill Introduced in U.S. Senate by International Narcotics Control Caucus in Favor of De-Scheduling CBD

Tucker Arensberg, P.C.
Contact

Leaders of the U.S. Senate’s International Narcotics Control Caucus, Sens. Dianne Feinstein (D-CA) and Chuck Grassley (R-IA), introduced a bill entitled the Cannabidiol Research Expansion Act, in the U.S. Senate on May 25, 2017 to expand authorized medical research of cannabidiol (CBD) and to deschedule it from a Schedule I controlled substance. In addition to Feinstein and Grassley, the bill is cosponsored by Senators Dick Durbin (D-Ill.), Thom Tillis (R-N.C.) and Joni Ernst (R-Iowa).

The timing perfectly coincided with the results published in New England Journal of Medicine of a study conducted on Dravet syndrome (suffering from epilepsy) patients concluding that the use of CBD reduced the number of convulsive-seizure frequency.

 

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Tucker Arensberg, P.C. | Attorney Advertising

Written by:

Tucker Arensberg, P.C.
Contact
more
less

Tucker Arensberg, P.C. on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.